World Dense Breast Day emphasizes the need for awareness and advocacy for individuals with dense breasts, which can ...

"As CMMI continues to test new equity adjustments, it is important that changes be grounded in scientific principles with ...

The 21st annual meeting of the International Myeloma Society takes place September 25-28, 2024, in Rio de Janiero, Brazil.

New research highlights increased stroke, heart attack, and heart failure risks in cancer survivors, especially those treated ...

Demonstration projects to show accurate use of artificial intelligence (AI) in cancer care are important to prevent a loss of ...

Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

A new study demonstrates that the combination of lenalidomide (Revlimid) and obinutuzumab (Gazyva) is effective and ...

Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...

A recent analysis investigated the state of metabolic disruption experienced by patients with spinal muscular atrophy (SMA), ...

Patients with sickle cell anemia (SCA) and persistent albuminuria (PA) exhibited significantly higher levels of urinary ...

Armstrong, MD, MPH, chief of dermatology, UCLA, discusses clinical trial findings from the phase 2b study on zasocitinib.

Joseph Alvarnas, MD, of City of Hope, discusses how he envisions the future of cancer care over the next decade.